Nishant Agrawal

Nishant Agrawal practices at The University of Chicago Medical Center in Chicago, Illinois.

Nishant Agrawal's NPI, 1265571061, was assigned on February 6, 2007. Nishant Agrawal graduated from The Johns Hopkins University School of Medicine in 2001. Nishant Agrawal holds Illinois license 036138902.

Nishant Agrawal's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Nishant Agrawal's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Nishant Agrawal is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Nishant Agrawal to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nishant Agrawal practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Nishant Agrawal's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Nishant Agrawal is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Nishant Agrawal's licenses on file in 4 states: Illinois, Maryland, Indiana and New York.

Dmand AI lists endoscopic sinus surgery, larynx and vocal cord disease and thyroid surgery among the conditions Nishant Agrawal treats.

CMS data shows 826 Medicare services from Nishant Agrawal across 9 procedure codes in 2024, for 347 Medicare patients. Medicare paid $61,288 for them.

CMS counts 347 Medicare patients who saw Nishant Agrawal in 2024. The largest group is 65 to 74, with 187 patients. 73% of them have high blood pressure, and 71% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nishant Agrawal's median patient age at 69, with 42% women.

In 2024, Nishant Agrawal wrote 198 Medicare Part D claims for 72 patients. 95% of them were for generic drugs. CMS names the drug for 127 of them, across 7 drugs with 11 or more claims each, at $2,798 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

Nishant Agrawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nishant Agrawal as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 140 papers to Nishant Agrawal, published from 2003 to 2025. 2020 was the busiest year, with 13. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Squamous Cell Carcinoma of Head and Neck. Nishant Agrawal has published most often in Head Neck. Nishant Agrawal's most frequent co-authors are Zhen Gooi, Alexander T. Pearson and Chetan Bettegowda, MD, PhD.

Dmand AI links Nishant Agrawal to 1 clinical trial. Conditions studied include Neoplasms, Squamous Cell and Squamous Cell Carcinoma of Head and Neck.

CMS Open Payments shows 36 general payments to Nishant Agrawal from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. Merck Sharp & Dohme Corporation paid the most, $17,640.

Dmand AI lists 5 awards for Nishant Agrawal, most recently CMS Stage 1 EHR in 2014.

Nishant Agrawal graduated from The Johns Hopkins University School of Medicine in 2001. Nishant Agrawal is a member of NHS, ACS and ATA.

Nishant Agrawal is in network with 10 carriers, including Aetna, Elevance and HCSC. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.